AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer

Figure 1

Expression variation and survival curves of AHCYL1 genes in colorectal cancer (CRC). (a) Kaplan-Meier graphs depicting the overall survival of patients with various AHCYL1 expression levels from TCGA database. (b) Using TCGA datasets, the position of AHCYL1 copy number variation (CNV) modification on chromosomes. (c) Kaplan-Meier curves comparing patients with AHCYL1 deletion to those with normal AHCYL1 expression from TCGA database. (d) AHCYL1 expression in various tissues.

(a)

(b)

(c)

(d)